Solid tumors are thought to contain cancer stem cells (CSCs) as a distinct population
responsible for tumor relapse and metastasis due to their abilities to self-renew, differentiate …

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most
frequent cause of cancer‐related death worldwide. Despite advances in its diagnosis and …

Liver cancer is an aggressive disease with a poor outcome. Several hepatic stem/progenitor
markers are useful for isolating a subset of liver cells with stem cell features, known as …

Hepatocellular carcinoma (HCC) is an aggressive tumour with a poor prognosis. Current
therapeutic strategies against this disease target mostly rapidly growing differentiated …

Hepatocellular carcinoma (HCC) is an aggressive disease with a poor clinical outcome. The
cancer stem cell (CSC) model states that tumour growth is powered by a subset of tumour …

Cancer stem cells (CSCs) are a small subpopulation in cancer, have been proposed to be
cancer-initiating cells, and have been shown to be responsible for chemotherapy resistance …

Hepatocellular carcinoma (HCC) is one of the most common human cancers. HCC is a
chemoresistant cancer and the current drug therapy has limited efficacy. As a result, the …

Although the “cancer stem cell (CSC)” hypothesis was first proposed roughly 50years ago,
recent progress in stem cell biology and technologies has successfully achieved the …

Recently, there has been growing support for the cancer stem cell (CSC) hypothesis, which
states that primary tumors are initiated and maintained by a small subpopulation of cancer …

Hepatocellular carcinoma (HCC) remains the most predominant type of liver cancer with an
extremely poor prognosis due to its late diagnosis and high recurrence rate. One of the …